Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 109

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 109
---
.12, respectively. The fair value of the options that vested during the years ended December 31, 2023, and 2022, was $ 166and $ 257, respectively.

As of December 31, 2023, there was $ 139of unrecognized share-based compensation expense related to unvested options. This unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately 2years based on vesting under the award service conditions.

The company issued and valued options using the Black-Scholes model
for all 2023 and 2022 issuances with the following significant assumptions.

| Fair value assumptions    |     | 2023 |            |   |     | 2022 |            |   |
| Expected volatility       |     |      |     45%-52 | % |     |      |     45%-52 | % |
| Expected terms (in years) |     |      |          4 |   |     |      |          4 |   |
| Risk-free interest rate   |     |      | 4.60%-5.46 | % |     |      | 1.48%-2.18 | % |
| Dividend Yield            |     |      |          0 | % |     |      |          0 | % |

The Company recognized compensation expenses related to stock options of $ 166during the year ended December 31, 2023 and $ 257for the year ended December 31, 2022.

15) Net Income per share The Company presents basic and diluted earnings per share (“EPS”) data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all potential dilutive shares, including awards under stock-based compensation arrangements. The basic and diluted EPS of the Company are the same. Since the Company has historically net losses, there is no diluted EPS. F-36

The Company’s unvested restricted stock awards are considered participating securities under FASB Codification topic, Earnings Per Share, because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a “participating security